Undisclosed BRD9 inhibitor / Rumi Scientific - LARVOL DELTA

Rumi Scientific Announces Partnership with X-Chem for Development of Lead Candidate in Huntington’s Disease (Yahoo Finance) - "Rumi Scientific...announced that it has entered into a partnership with X-Chem, the leading provider of innovative solutions in early-stage drug discovery, through which X-Chem will develop a lead candidate BRD9 inhibitor for the treatment of Huntington’s Disease (HD)....'We look forward to working closely with the team at X-Chem on the development of the lead molecule, and to advancing it toward clinical studies.'"

Licensing / partnership • Genetic Disorders • Huntington's Disease